drug
diclofenac potassium
Marketedupdated 5mo agoby Amici Pharmaceuticals LLC
Approvedcommunity read0 votes
indications
investigational
Rheumatoid Arthritis
all catalysts(0)
nothing on the calendar yet
Trials studying diclofenac potassium
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 24, 2029
~2.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (10)
- Feb 24, 2029method-of-use (U-1035)US 76628582.4y
- Feb 24, 2029method-of-use (U-1111)US 78840952.4y
- Feb 24, 2029method-of-use (U-980)US 79395182.4y
- Feb 24, 2029method-of-use (U-980)US 81106062.4y
- Feb 24, 2029method-of-use (U-1482)US 86239202.4y
- Feb 24, 2029method-of-use (U-1482)US 95612002.4y
- Jun 16, 2026compositionUS 7759394
- Jun 16, 2026compositionUS 8097651
- Jun 16, 2026method-of-use (U-436)US 8927604
- Jun 16, 2026formulationUS 9827197
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that